Cargando…

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children

BACKGROUND: House dust mites (HDM) are the major causative allergen for allergic rhinitis. The sole disease-modifying therapy for allergic rhinitis is allergen immunotherapy (AIT). Rush immunotherapy is the accelerated build-up schedules to reach the target maintenance dose. OBJECTIVE: To evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rattanamanee, Tipyapa, Lumjiaktase, Putthapoom, Kemawichanura, Nanthisa, Kiewnga, Potjanee, Jotikasthira, Wanlapa, Manuyakorn, Wiparat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819415/ https://www.ncbi.nlm.nih.gov/pubmed/35174055 http://dx.doi.org/10.5415/apallergy.2022.12.e4

Ejemplares similares

Efficacy of Nasal Cellulose Powder in the Symptomatic Treatment of Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Manuyakorn, Wiparat, et al.
Publicado: (2017)

Forced oscillation technique as a predictor for loss of control in asthmatic children
por: Kreetapirom, Piyawut, et al.
Publicado: (2020)

Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
por: Lee, So-Hee, et al.
Publicado: (2019)

Prevalence and Clinical Characteristics of Local Allergic Rhinitis to House Dust Mites
por: Jung, Chang-Gyu, et al.
Publicado: (2017)

Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis
por: Ma, Yun, et al.
Publicado: (2020)

A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
por: Lee, Ji-Ho, et al.
Publicado: (2018)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

TSLP receptor is not essential for house dust mite-induced allergic rhinitis in mice
por: Nakanishi, Wakako, et al.
Publicado: (2016)

Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?
por: Muntean, Ioana Adriana, et al.
Publicado: (2020)

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022)

Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite
por: Duan, Su, et al.
Publicado: (2021)

Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics
por: Uchida, Takahiro, et al.
Publicado: (2021)

Berberine reduce allergic inflammation in a house dust mite allergic rhinitis mouse model
por: Kim, Soo Whan
Publicado: (2015)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children
por: Leger, Damien, et al.
Publicado: (2017)

IL-25 Could Be Involved in the Development of Allergic Rhinitis Sensitized to House Dust Mite
por: Kim, Dae Woo, et al.
Publicado: (2017)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis
por: Kim, Sae-Hoon, et al.
Publicado: (2018)

Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patients
por: Callebaut, Ina, et al.
Publicado: (2020)

Exposure to House Dust Mite Allergen and Endotoxin in Early Life and Sensitization and Allergic Rhinitis: The JECS
por: Kojima, Reiji, et al.
Publicado: (2022)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021)

Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling
por: Xie, Shaobing, et al.
Publicado: (2022)

House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up
por: Rodriguez‐Plata, Elena, et al.
Publicado: (2023)

Novel salivary gland allergens from tropical mosquito species and IgE reactivity in allergic patients()
por: Opasawatchai, Anunya, et al.
Publicado: (2020)

Regulation of Constitutive Neutrophil Apoptosis Due to House Dust Mite Allergen in Normal and Allergic Rhinitis Subjects
por: Kim, Eun Hye, et al.
Publicado: (2014)

IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic Rhinitis
por: Nakanishi, Wakako, et al.
Publicado: (2013)

Elevated Levels of Activated and Pathogenic Eosinophils Characterize Moderate-Severe House Dust Mite Allergic Rhinitis
por: Chen, Yang, et al.
Publicado: (2020)

Strain-Specific Differences in House Dust Mite (Dermatophagoides farinae)-Induced Mouse Models of Allergic Rhinitis
por: Lee, Ki-Il, et al.
Publicado: (2020)

Validated allergen exposure chamber is plausible tool for the assessment of house dust mite‐triggered allergic rhinitis
por: Zemelka‐Wiacek, Magdalena, et al.
Publicado: (2022)

Allergic rhinitis behavioral changes after Indonesian house dust mites allergenic extract administration as immunotherapy
por: Pratama, Yusuf Alif, et al.
Publicado: (2023)

Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust
por: Lim, Fang Lee, et al.
Publicado: (2015)

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
por: Bożek, Andrzej, et al.
Publicado: (2017)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis
por: Kim, Sang Hoon, et al.
Publicado: (2014)

Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites
por: Kim, Shin Hye, et al.
Publicado: (2015)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
por: Ellis, Anne K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ilbtkpfsnk2uh7na814io55s3n